Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Why these 2 ASX growth shares have done so well

Learning from the past can help build a better future. Why have Pro Medicus Limited (ASX: PME) and Xero Limited (ASX: XRO) done so well?

Learning from the past can help build a better future. Let’s action this and zoom in on the share prices of Pro Medicus Limited (ASX: PME) and Xero Limited (ASX: XRO).

Both Pro Medicus and Xero have performed incredibly well over the last five years but why?

Pro Medicus share price

Source: Rask Media PME 5-year share price chart

Pro Medicus develops and supplies healthcare imaging software and services to hospitals, diagnostic imaging groups and other health-related entities.

The company developed its key software product, Visage 7.0 that continues to be number 1 in terms of speed, functionality and scalability. It’s obvious now but what about when it was in its early stages of development?

A sound signal of the quality of a product is monitoring the reputation of its initial customers. In Pro Medicus’ case, it managed to secure contracts with a few of the biggest hospitals in the US, which can be a tell-tale sign of a high-quality product.

Another important driver of growth was that the software was highly scalable with high gross and operating margins.

Source: TIKR

Since the software had little marginal cost, Pro Medicus was able to rapidly grow its operating margins. This results in more free cash flow.

Xero share price

Source: Rask Media XRO 5-year share price chart

A similar story unfolded with respect to Xero.

Xero set out to disrupt the incumbent accounting platform provider, MYOB. Xero managed to develop a much better and easier to use accounting and business platform.

Talking to your personal accountant or even monitoring the recipients of major awards could have been some ways to gauge the quality of Xero. Xero was awarded as New Zealand’s Company of the Year by the NZ Hi-Tech Awards back in 2015.

It’s always easy easier in hindsight but the purpose of this piece is to learn from the past and build a better future.

Xero managed to produce a high-quality product and managed to scale rapidly due to the capital-light nature of the product offering. This is reflected by the steep rise in gross margins and operating margins.

Source: TIKR

Both businesses have been able to generate free cash flow and continue to reinvest capital into improving their existing products and solutions.

These businesses align with the Rask Investment Philosophy as they continue to operate in structurally growing industries.

These are only a couple of reasons why these businesses have done so well. If you are interested in a deeper dive into these 2 ASX growth shares, check out this podcast.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content